Atea Pharmaceuticals Earning Date (AVIR)

USA |NASDAQ |USD

AVIR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 30, 2022 (est) Dec 31, 2021 - $-0.34 $2.62
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 30, 2022 (est) Dec 31, 2021 - $159.19M $48.63M

Atea Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Mar 30, 2022 for the fiscal quarter ending Dec 31, 2021.

AVIR Earnings Date & History Chart

AVIR Earnings & Revenue Forecast

AVIR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.24 $-0.77 $0.14
Mar 2022 1 $-0.74 $-0.74 $-0.74
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.17 $-0.72 $0.73
Dec 2022 4 $0.30 $-1.90 $3.56

AVIR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $0.36 $0.36 $0.30
Mar 2022 0 / 0 $-0.29 $-0.29 $-0.14
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $0.58 $0.58 $0.49
Dec 2022 0 / 0 $15.60 $14.30 $12.06

AVIR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $36.80M $0.00 $60.39M
Mar 2022 1 $66.00M $66.00M $66.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $245.98M $159.00M $301.37M
Dec 2022 4 $294.61M $50.00M $63.75M

AVIR Earnings Date & Revenue History

AVIR Earnings History

|
Show More
Show More

AVIR Revenue History

|
Show More
Show More

Atea Pharmaceuticals Next Earnings Date & Report

AVIR Nov 2021 (FQ) Earnings Date & Report Preview

AVIR's next estimated earnings date (based on same quarter last year's report date) is Mar 30, 2022 for the fiscal quarter ending Dec 31, 2021.

Atea Pharmaceuticals Previous Earnings Dates & Reports

AVIR Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Atea Pharmaceuticals's previous earnings date was Nov 11, 2021 for its fiscal quarter ended Sep 30, 2021.

AVIR's earnings per share (EPS) was $-0.34, missing the consensus analysts forecast of $-0.05 by -547.62%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by -1800.00%, and higher than the same period a year before (Sep 2020) by -80.46%.

Revenues were $159.19M.

The company reported a net income of $30.66M.

Free cash flow for the quarter was $22.60M , compared to $-17.35M last quarter and $-9.50M a year before.

AVIR Previous Earnings Date & Report Recap: Dec 2020 (FY)

Atea Pharmaceuticals's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

AVIR's earnings per share (EPS) was $0.88, missing the consensus analysts forecast of $1.40 by -37.14%.

Revenues were $48.63M.

The company reported a net income of $-10.95M.

Atea Pharmaceuticals reported a free cash flow of $296.71M for its fiscal year, compared to $-12.82M a year ago.